Ledger.Open graph →
SEC Form D · filed December 8, 2016

FATE THERAPEUTICS INC

Offering
$56.7M
Sold
$56.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

John S. Mendlein · SAN DIEGO, CADirectorRobert S. Epstein · SAN DIEGO, CADirectorCindy D. Tahl · SAN DIEGO, CAExecJ. Scott Wolchko · San Diego, CAExec · DirectorWilliam S. Rastetter · SAN DIEGO, CADirectorTimothy P. Coughlin · SAN DIEGO, CADirectorAmir S. Nashat · SAN DIEGO, CADirectorMark J. Enyedy · San Diego, CADirectorChris D. Storgard · San Diego, CAExecStewart S. Abbot · San Diego, CAExecDaniel D. Shoemaker · San Diego, CAExecJohn S. Mendlein · SAN DIEGO, CADirectorRobert S. Epstein · Waltham, MADirectorCindy D. Tahl · SAN DIEGO, CAExecJ. Scott Wolchko · San Diego, CAExec · DirectorMark J. Enyedy · San Diego, CADirectorWilliam S. Rastetter · SAN DIEGO, CADirectorTimothy P. Coughlin · SAN DIEGO, CADirectorChris D. Storgard · San Diego, CAExecAmir S. Nashat · SAN DIEGO, CADirectorStewart S. Abbot · San Diego, CAExecDaniel D. Shoemaker · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗